PLEASANTON, CA–(Marketwire – November 15, 2011) – CooperVision announced today that it is expanding its worldwide recall of the Avaira brand product line of contact lenses to include a limited number of lots of Avaira Sphere contact lenses. In continued collaboration with the United States Food and Drug Administration, CooperVision is expanding the recall because [...]

MOUNTAIN VIEW, CA–(Marketwire – 02/03/11) – Hansen Medical, Inc. (NASDAQ:HNSN – News), a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, today announced that it has entered, directly and through a wholly owned subsidiary, into patent and technology license, sublicense and purchase agreements with Philips [...]

BOHEMIA, NY–(Marketwire – November 12, 2010) – Highlighted Links http://www.Vycormedical.com NovaVision Vycor Medical, Inc. (OTCBB: VYCO) (www.vycormedical.com), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced the entry into a purchase agreement to acquire the assets of NovaVision, Inc., including its German subsidiary, NovaVision AG (together “NovaVision”) for an [...]

REUTLINGEN, Germany–(BUSINESS WIRE)– Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the opening of a new manufacturing plant to meet anticipated demand for their implants. The company’s second human clinical trial will be expanding outside of Germany in early 2011 to European countries including the U.K. and Italy [...]

HONOLULU, Aug. 31 /PRNewswire/ — Eyegenix , the ophthalmic division of Cellular Bioengineering, Inc. (CBI), announced today that the results of a pilot clinical trial using a synthetic cornea for which Eyegenix holds the exclusive global license for transplantation were published in the peer-reviewed journal, Science Translational Medicine (Volume 2, Issue 46, August, 25, 2010). The publication [...]

MONROVIA, Calif., Aug. 17 /PRNewswire-FirstCall/ — STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has made two key additions to its executive management team. Donald J. Todd, (57), was named to the position of President of Asia/Pacific. William W. Goodmen, (56), was appointed to the newly-created [...]